<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F"><gtr:id>A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F</gtr:id><gtr:name>University of Guelph</gtr:name><gtr:address><gtr:line1>50 Stone Rd E</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Molecular Biology and Biotechnology</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F"><gtr:id>A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F</gtr:id><gtr:name>University of Guelph</gtr:name><gtr:address><gtr:line1>50 Stone Rd E</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/18399BAB-0F5F-40AC-A58F-4E46BED16C50"><gtr:id>18399BAB-0F5F-40AC-A58F-4E46BED16C50</gtr:id><gtr:firstName>Simon J.</gtr:firstName><gtr:surname>Foster</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DC3E968D-06C2-4F03-9987-D58301F99BC6"><gtr:id>DC3E968D-06C2-4F03-9987-D58301F99BC6</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Gerrard</gtr:otherNames><gtr:surname>Dowson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B1C03689-7FB3-4F37-9456-6CD786EA93DF"><gtr:id>B1C03689-7FB3-4F37-9456-6CD786EA93DF</gtr:id><gtr:firstName>Hee-Jeon</gtr:firstName><gtr:surname>Hong</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1FD4D789-FFE2-40DF-91BF-73143F6A553A"><gtr:id>1FD4D789-FFE2-40DF-91BF-73143F6A553A</gtr:id><gtr:firstName>David Ian</gtr:firstName><gtr:surname>Roper</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DDBB3F10-D3B5-4C13-BD8E-415EF8EBE9C9"><gtr:id>DDBB3F10-D3B5-4C13-BD8E-415EF8EBE9C9</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:otherNames>David Howard</gtr:otherNames><gtr:surname>Bugg</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701400"><gtr:id>5BCAA4B5-CCBA-428A-B918-EFB27285BF4D</gtr:id><gtr:title>UK-BaCWAN2: Continuation and Expansion of UK-Bacterial Cell Wall Assembly Network</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701400</gtr:grantReference><gtr:abstractText>Millions of people die each year from bacterial infections and tens of millions suffer from the consequences of these infections. The discovery of the antibiotic penicillin once opened the door to treat these infections by stopping bacteria making the polymer in the cell wall that holds them together. This polymer, called peptidoglycan, is made up of an interlocking network of sugars and strings of amino acids (peptides). Specialised proteins (called PBPs), with the ability to stitch together these sugars and peptides are the targets inhibited by penicillin, stopping cell wall synthesis and killing the bacterium. Many important bacteria are now no longer killed by penicillin and other antibiotics that attack other stages in the production of peptidoglycan. Bacteria have changed, evading the action of these antibiotics. We need to fight back, by using the advanced computing power at our disposal to design new classes of antibiotics, compounds that will work against multiply resistant bacteria like MRSA, and help combat the harmful effects of our immune system when it over responds to infection. 
BACWAN consists of a group of scientists from academia, industry and government whose goals is increase and coordinate activity in his area to bring about new treatments and strategies. They will have, for the first time, the combined tools and new chemical reagents (to be made for the team at a cost efficient central location at Warwick) to look in minute detail how peptidoglycan is made, how we could stop this process by the development of new inhibitors (antibiotics) and how fragments of peptidoglycan interact with our bodies during the process of infection. This capacity for discovery, being lost elsewhere, will provide a unique forum for the development of new compounds.</gtr:abstractText><gtr:technicalSummary>The process of assembly of the bacterial cell wall is a validated and important target for the development of novel antibacterial agents, and is intimately connected with the emergence of antibiotic resistance around the world. Significant research programmes in this area are carried out in UK laboratories, but at present these activities are somewhat fragmented, between groups in Chemistry, Physics, and Biology departments following different areas related to this problem. Our existing UK Network in bacterial cell wall assembly, has been successful in bringing together some of these groups with expertise in different disciplines and provide a forum for the additional involvement of industrial and healthcare associated scientists, to inform the network of industrial interests and emerging techniques and areas of interest. We now wish to capitalise and expand upon this network by recruiting further members and promoting excellent scientific collaboration. The principal vehicle for this network will be a series of bi-yearly meetings involving chemists, biochemists, microbiologists, computational, industrial and physical scientists to stimulate new inter-disciplinary research and collaboration in this area. Our website provides a useful additional level of information for our members and distributes information to members, other scientists and the general public will also augment these meetings. We also wish to facilitate new collaborative research programmes that will arise from this network by funding inter-laboratory and interdisciplinary visits for students, postdoctoral researchers and PIs, enabling technology and technique transfer to stimulate future research efforts within the UK scientific community.</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>251120</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>Research Collaboration</gtr:description><gtr:id>537E8325-91F2-4E37-8FC5-E6B140335901</gtr:id><gtr:impact>Joint grant applications</gtr:impact><gtr:outcomeId>4A1A42A14D3-1</gtr:outcomeId><gtr:partnerContribution>Research collaboration leading to future grant applicationsResearch collaboration, student exchange</gtr:partnerContribution><gtr:piContribution>Research Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Cell and Molecular Biosciences</gtr:department><gtr:description>Research Collaboration</gtr:description><gtr:id>55F8327B-743C-4DC1-8618-B0C9E7857595</gtr:id><gtr:impact>Joint grant applications</gtr:impact><gtr:outcomeId>4A1A42A14D3-2</gtr:outcomeId><gtr:partnerContribution>Research collaboration leading to future grant applicationsResearch collaboration, student exchange</gtr:partnerContribution><gtr:piContribution>Research Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Guelph</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Canada</gtr:description><gtr:id>A2D63403-565A-4537-BA56-7C3EC9E410A9</gtr:id><gtr:impact>Joint grant applications</gtr:impact><gtr:outcomeId>tPKUD33TYbc-1</gtr:outcomeId><gtr:partnerContribution>A UK Canada consortium in the area of Bacterial Cell Walls. Mutual collaborative visits have been made.</gtr:partnerContribution><gtr:piContribution>Research presentations and ideas</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Getting to grips with antibiotic resistance</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3EE42492-6393-4617-960B-8154A155C5DF</gtr:id><gtr:impact>The School of Life Sciences at Warwick hosted members of the public and press for a presentational evening with talks, lab tours and demonstrations in an event entitled: &amp;quot;Getting to grips with antibiotic resistance&amp;quot; This event was held in antibiotic awareness week in November 2016 and hosted around 90 visitor</gtr:impact><gtr:outcomeId>58c02c947f9c47.00975096</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www2.warwick.ac.uk/fac/sci/lifesci/outreach/next/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>C1BC620E-B884-4DB8-9C09-335C0C75085F</gtr:id><gtr:impact>Web cast and press release outlining work at Warwick and wider network

Invitation to speak, further public understanding of science presentations</gtr:impact><gtr:outcomeId>ECDC9B7EC6A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit Shrewsbury</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>A0EACCDD-0F53-44D8-9D4E-FB4775F8DE2A</gtr:id><gtr:impact>Schools visit and promotion

Invitation to return</gtr:impact><gtr:outcomeId>15B4C7F56DA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit - Hathersage</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>A76BA8D6-0B15-410A-AAAD-560500F864E2</gtr:id><gtr:impact>Introduction to microbiology. This included oral and practical sessions.

No subsequent impact</gtr:impact><gtr:outcomeId>FA3BA06BB55</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>The BACWAN synthetic facility has developed a range of peptidoglycan intermediates that are available to the scientific community for use in research and assay development</gtr:description><gtr:id>00492899-C294-4AC7-BBE7-9B696E3AA2E1</gtr:id><gtr:impact>These intermediates are already having an impact on advancing the development of novel assays and routes for antibiotic discovery as well as basic science</gtr:impact><gtr:outcomeId>111C06CF9A2</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Peptidoglycan intermediates availible to Scientific community</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9767E193-F9B8-4DC7-96F5-B4D97B9F6CC3</gtr:id><gtr:title>Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins.</gtr:title><gtr:parentPublicationTitle>Infectious disorders drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f7a02442d81e889671ae7bb0cfefd6f"><gtr:id>5f7a02442d81e889671ae7bb0cfefd6f</gtr:id><gtr:otherNames>Bugg TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1871-5265</gtr:issn><gtr:outcomeId>96972788020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B5F594E-ECF8-4F14-A976-11246C2EB509</gtr:id><gtr:title>Structure of the diaminopimelate epimerase DapF from Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286e637dccc3e05c93cc3ebe3583bb1c"><gtr:id>286e637dccc3e05c93cc3ebe3583bb1c</gtr:id><gtr:otherNames>Usha V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>3E1EE58983A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EEDD802-497F-44E9-B67B-C5FF5CF31E55</gtr:id><gtr:title>Pseudomonas aeruginosa MurE amide ligase: enzyme kinetics and peptide inhibitor.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8c2efad2f3086b8203550051fe5ee4d"><gtr:id>b8c2efad2f3086b8203550051fe5ee4d</gtr:id><gtr:otherNames>Paradis-Bleau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>1D5FC1D9077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2E733F7-697E-42EC-8859-278F990A961B</gtr:id><gtr:title>Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d9a44e5e7a61959fd7e4276275fb157"><gtr:id>7d9a44e5e7a61959fd7e4276275fb157</gtr:id><gtr:otherNames>Lloyd AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>89A1FF0B2E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6DBBA20-D35D-4EC2-A8E7-D67EFF037C72</gtr:id><gtr:title>Kinetic characterization of lipid II-Ala:alanyl-tRNA ligase (MurN) from Streptococcus pneumoniae using semisynthetic aminoacyl-lipid II substrates.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cff8d9647660a115bdcd0780da91b57"><gtr:id>5cff8d9647660a115bdcd0780da91b57</gtr:id><gtr:otherNames>De Pascale G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>EDE54086165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>398AB38F-99C2-4610-B0E9-4B72E72490E6</gtr:id><gtr:title>Mutational analysis of the substrate specificity of Escherichia coli penicillin binding protein 4.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32918b04931fabb0631d6ae72adc8bf8"><gtr:id>32918b04931fabb0631d6ae72adc8bf8</gtr:id><gtr:otherNames>Clarke TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>D8281D9814C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A07F4925-942A-436D-AC65-491AA6BE21A4</gtr:id><gtr:title>Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to ?-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3379d5e7a29f0f27d92c724da2a3ca2"><gtr:id>f3379d5e7a29f0f27d92c724da2a3ca2</gtr:id><gtr:otherNames>Renzoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>58b7e543525742.95991139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEDCDFB7-7EE8-46B4-B774-6720F0D22E8D</gtr:id><gtr:title>Crystal structure of penicillin binding protein 4 (dacB) from Escherichia coli, both in the native form and covalently linked to various antibiotics.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1da6a367fe4a465c03e0888c484b112b"><gtr:id>1da6a367fe4a465c03e0888c484b112b</gtr:id><gtr:otherNames>Kishida H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>51DB99326D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB8B56D5-BFB6-4180-96FA-5994EC44CBCC</gtr:id><gtr:title>Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cff11cd2c359666d4f4782b083b20fb1"><gtr:id>cff11cd2c359666d4f4782b083b20fb1</gtr:id><gtr:otherNames>Lysenko ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>57CB7064EC9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3F4D33C-EF98-4295-B363-E2006DE41097</gtr:id><gtr:title>Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB).</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc76e1e0552de72eb6ee20f503787e3"><gtr:id>bcc76e1e0552de72eb6ee20f503787e3</gtr:id><gtr:otherNames>Sova M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>CEF1A2DD599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D83C467A-44F9-459F-AF8F-6A660072EBA8</gtr:id><gtr:title>Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fc69d5be4c1fa2234e04140b7de0313"><gtr:id>6fc69d5be4c1fa2234e04140b7de0313</gtr:id><gtr:otherNames>Cressina E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>6358D366A60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D6EAA8C-7CAB-4808-B61C-82B1709CE7B5</gtr:id><gtr:title>Zn(II) mediates vancomycin polymerization and potentiates its antibiotic activity against resistant bacteria.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b99a2f2ca8b7dff6775760c66ba6a4ce"><gtr:id>b99a2f2ca8b7dff6775760c66ba6a4ce</gtr:id><gtr:otherNames>Zarkan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9fc02702cd72.24563384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70DFA2D9-2841-432D-94A8-5E4E7FA13CC5</gtr:id><gtr:title>Crystal structures of penicillin-binding proteins 4 and 5 from Haemophilus influenzae.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ecf4baeab768941a6d4e197e3d279e8"><gtr:id>3ecf4baeab768941a6d4e197e3d279e8</gtr:id><gtr:otherNames>Kawai F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>4880D0CFC97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEC866F6-87C7-4D57-B4AF-6092FBF82854</gtr:id><gtr:title>Characterization of Mycobacterium tuberculosis diaminopimelic acid epimerase: paired cysteine residues are crucial for racemization.</gtr:title><gtr:parentPublicationTitle>FEMS microbiology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286e637dccc3e05c93cc3ebe3583bb1c"><gtr:id>286e637dccc3e05c93cc3ebe3583bb1c</gtr:id><gtr:otherNames>Usha V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0378-1097</gtr:issn><gtr:outcomeId>02F048ABE49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A187798C-EAA3-41C8-9CEC-1707A4168093</gtr:id><gtr:title>Fluorescent reagents for in vitro studies of lipid-linked steps of bacterial peptidoglycan biosynthesis: derivatives of UDPMurNAc-pentapeptide containing d-cysteine at position 4 or 5.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee62c7d4e797a1b215c3e09aba0b983d"><gtr:id>ee62c7d4e797a1b215c3e09aba0b983d</gtr:id><gtr:otherNames>Schouten JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>964F843556C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1726CB26-50A4-46AE-9A49-53F4B646758F</gtr:id><gtr:title>Adenosine phosphonate inhibitors of lipid II: alanyl tRNA ligase MurM from Streptococcus pneumoniae.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fc69d5be4c1fa2234e04140b7de0313"><gtr:id>6fc69d5be4c1fa2234e04140b7de0313</gtr:id><gtr:otherNames>Cressina E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>74BA921B781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7402190C-61DB-409B-876F-42DCA2959F43</gtr:id><gtr:title>Expression, purification and characterisation of soluble GlfT and the identification of a novel galactofuranosyltransferase Rv3782 involved in priming GlfT-mediated galactan polymerisation in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/938585ac20ff7a91cc730466157b3634"><gtr:id>938585ac20ff7a91cc730466157b3634</gtr:id><gtr:otherNames>Alderwick LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn><gtr:outcomeId>DE49A763869</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701400</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>